This study showed that EOC patients with coexisting EM (EAOC group) were characterized by a younger age of onset, a higher percentage of premenopausal status, lower preoperative CA125 levels, an early tumor stage, a greater extent of satisfying tumor debulking, less opportunity of lymph node metastasis and developing chemo-resistance. This evidence concerns the gene MUC16 and neoplasm.